Aducanumab as a Novel Treatment for Alzheimer’s Disease: A Decade of Hope, Controversies, and the Future-Reference-Cited by-同舟云学术

Aducanumab as a Novel Treatment for Alzheimer’s Disease: A Decade of Hope, Controversies, and the Future

Published:2021-08-31 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Esang Michael,Gupta Mayank

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference19 articles.

1. Dementia. (2020). Accessed. August 23, 2021: https://www.who.int/news-room/fact-sheets/detail/dementia.

2. Alzheimer's Association. Milestones. (2021). Accessed. August 23, 2021: https://www.alz.org/alzheimers-dementia/research_progress/milestones.

3. Alzheimer's Association. Medications for memory, cognition and dementia-related behaviors. (2021). Accessed. August 23, 2021: https://www.alz.org/alzheimers-dementia/treatments/medications-for-memory.

4. The Maudsley prescribing guidelines in psychiatry;Taylor DM,2018

5. Alzheimer's Association. Aducanumab approved for treatment of Alzheimer’s Disease. (2021). Accessed. August 23, 2021: https://www.alz.org/alzheimers-dementia/treatments/aducanumab.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides;Current Protein & Peptide Science;2024-09

2. Amyloid-β neuropathology induces bone loss in male mice by suppressing bone formation and enhancing bone resorption;Bone Reports;2024-06

3. Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer’s disease, Alzheimer’s disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis;International Psychogeriatrics;2024-02-08

4. Optimized Pre-analytical Handling Protocol for Blood-Based Biomarkers of Alzheimer’s Disease;Methods in Molecular Biology;2024